Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.

CME information and select publications here.

Community discussion

Join the conversation

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

You May Also Like

The Grave Talks | Haunted, Paranormal & Supernatural

HOLOSKY PODCAST

Hidden Brain

Research Insights, a Society of Actuaries Podcast

The Resetter Podcast with Dr. Mindy

Radiowissen

The Best of Coast to Coast AM

The 365 Days of Astronomy

Real Ghost Stories Online

Breaking Down: Collapse